The DOI matches its Crossref record, with a small difference in title or year; 41 of the 41 references it cites were found in a registry or an index.
Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes
Open accessAbstract
Mixed lineage kinase 3 (MLK3) deficiency reduces macrophage‐associated inflammation in a murine model of nonalcoholic steatohepatitis (NASH). However, the mechanistic links between MLK3 activation in hepatocytes and macrophage‐driven inflammation in NASH are uncharted. Herein, we report that MLK3 mediates the release of (C‐X‐C motif) ligand 10 (CXCL10)‐laden extracellular vesicles (EVs) from lipotoxic hepatocytes, which induce macrophage chemotaxis. Primary mouse hepatocytes (PMHs) and Huh7 cells were treated with palmitate or lysophosphatidylcholine (LPC). Released EVs were isolated by differential ultracentrifugation. LPC treatment of PMH or Huh7 cells induced release of EVs, which was prevented by either genetic or pharmacological inhibition of MLK3. Mass spectrometry identified the potent chemokine, CXCL10, in the EVs, which was markedly enriched in EVs isolated from LPC‐treated hepatocytes versus untreated cells. Green fluorescent protein (GFP)‐tagged CXCL10 was present in vesicular structures and colocalized with the red fluorescent protein (RFP)‐tagged EV marker, CD63, after LPC treatment of cotransfected Huh‐7 cells. Either genetic deletion or pharmacological inhibition of MLK3 prevented CXCL10 enrichment in EVs. Treatment of mouse bone‐marrow–derived macrophages with lipotoxic hepatocyte‐derived EVs induced macrophage chemotaxis, an effect blocked by incubation with CXCL10‐neutralizing antisera. MLK3‐deficient mice fed a NASH‐inducing diet had reduced concentrations of total plasma EVs and CXCL10 containing EVs compared to wild‐type mice. Conclusions: During hepatocyte lipotoxicity, activated MLK3 induces the release of CXCL10‐bearing vesicles from hepatocytes, which are chemotactic for macrophages. (H epatology 2016;63:731–744)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They also secrete inflammatory and fibrogenic cytokines either directly, such as interleukin (IL)-1β and IL-18,35,36 or via extracellular vesicles containing C-X-C motif chemokine ligand (CXCL)10, a ligand for C-X-C motif chemokine receptor (CXCR)3, and mitochondrial DNA, a key TLR9 ligand.37”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Colombo, M., Moita, C. F., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L. F., Théry, C., & Raposo, G. (2013) · Journal of Cell Science · doi:10.1242/jcs.128868 · Cited by 1,534
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Self-citationNeuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
CXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,006
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 230
Alsuraih, M., Trussoni, C. E., Splinter, P. L., LaRusso, N. F., & O’Hara, S. P. (2020) · Liver International · doi:10.1111/liv.14569 · Cited by 40
Wang, X., & Peng, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.655557 · Cited by 42
Newman, L. A., Sorich, M. J., & Rowland, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072032 · Cited by 42
Azparren‐Angulo, M., Royo, F., González, E., Patricio-Liébana, M., Brotons, B., Berganza, J., Goñi‐de‐Cerio, F., Manicardi, N., Abad‐Jordà, L., Gracia‐Sancho, J., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107683 · Cited by 38
Comprehensive Analysis of NAFLD and the Therapeutic Target Identified
Wen, W., Wu, P., Zhang, Y., Chen, Z., Sun, J. M., & Chen, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.704704 · Cited by 39
Luo, N., Yang, C., Zhu, Y., Chen, Q., & Zhang, B. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06652 · Cited by 37
Liang, Y., Kaushal, D., & Wilson, R. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147943 · Cited by 40
Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis
Tomita, K., Kohli, R., MacLaurin, B. L., Hirsova, P., Guo, Q., Sanchez, L. H. G., Gelbard, H. A., Blaxall, B. C., & Ibrahim, S. H. (2017) · JCI Insight · doi:10.1172/jci.insight.94488 · Cited by 35
Self-citationFunction and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease
Chen, W., Zhang, J., Fan, H., & Zhu, J. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818815184 · Cited by 36
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions
Notarnicola, M., Osella, A. R., Caruso, M. G., Pesole, P. L., Lippolis, A., Tutino, V., Bonfiglio, C., Nunzio, V. D., Scavo, M. P., Mirizzi, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083899 · Cited by 34
Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis
García‐Martinez, I., Alén, R., Rada, P., & Valverde, Á. M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00395 · Cited by 32
Park, S., & Hahn, Y. S. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0032 · Cited by 35
Katsumi, T., Guicciardi, M. E., Azad, A. I., Bronk, S. F., Krishnan, A., & Gores, G. J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00250.2019 · Cited by 32
Self-citationExosomes as therapeutic vehicles in liver diseases
Ding, J., Wang, J., & Chen, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5422 · Cited by 31
Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications
Ibrahim, S. H. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00009.2021 · Cited by 31
Self-citationAg-driven CD8+ T cell clonal expansion is a prominent feature of MASH in humans and mice
Burtis, A. E. C., DeNicola, D. M. C., Ferguson, M. E., Santos, R. G., Pinilla, C., Kriss, M. S., Orlicky, D. J., Tamburini, B. A. J., Gillen, A. E., & Burchill, M. A. (2025) · Hepatology · doi:10.1097/hep.0000000000000971 · Cited by 30
Buratta, S., Shimanaka, Y., Costanzi, E., Ni, S., Urbanelli, L., Kono, N., Morena, F., Sagini, K., Giovagnoli, S., Romani, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84268-9 · Cited by 30
A Teleost CXCL10 Is Both an Immunoregulator and an Antimicrobial
Li, H., Sun, Y., & Sun, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.917697 · Cited by 30
McCullough, R. L., McMullen, M. R., Poulsen, K. L., Kim, A., Medof, M. E., & Nagy, L. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02133 · Cited by 30
The diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 31
Vachliotis, I. D., & Pοlyzos, S. A. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00657-5 · Cited by 31
Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis
Hirsova, P., Böhm, F., Dohnalkova, E., Nožičková, B., Heikenwalder, M., Gores, G., & Weber, A. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2283-9 · Cited by 27
Self-citationRey-Bedón, C., Banik, P. D., Gökaltun, A., Hofheinz, O., Yarmush, M. L., Uygun, M. K., & Usta, O. B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112377 · Cited by 31
Crucial role of T cells in NAFLD-related disease: A review and prospect
Mao, T., Yang, R. X., Luo, Y., & He, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1051076 · Cited by 29
Xia, H.-F., Yu, Z., Zhang, L., Liu, S., Zhao, Y. F., Huang, J., Fu, D., Xie, Q., Liu, H., Zhang, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202205566 · Cited by 28
Exosomes in esophageal cancer: A review on tumorigenesis, diagnosis and therapeutic potential
Su, L., Chang, X., Zhou, H., Hou, L., & Xue, X. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i8.908 · Cited by 28
Role of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Alcohol-Induced Liver Injury
Chhetri, G., Liang, Y., Shao, J., Han, D., Yang, Y., Hou, C., Wang, P., Tao, X., Shen, Y., Jiang, T., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9034864 · Cited by 28
Exosomes: Nomenclature, Isolation, and Biological Roles in Liver Diseases
Park, S. H., Lee, E. K., Yim, J., Lee, M. H., Lee, E., Lee, Y., & Seo, W. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.161 · Cited by 29
High‐fat diets: You are what you eat….your extracellular vesicles too!
Rome, S., & Tacconi, S. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12382 · Cited by 27
Alchera, E., Rolla, S., Imarisio, C., Bardina, V., Valente, G., Novelli, F., & Carini, R. (2016) · Translational research · doi:10.1016/j.trsl.2016.11.009 · Cited by 27
Li, W., & Yu, L. (2024) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2024.2360008 · Cited by 27
Extracellular vesicles participate in macrophage-involved immune responses under liver diseases
Shao, J., Li, S., Liu, Y., & Zheng, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117094 · Cited by 25
Kriss, M. S., Golden‐Mason, L., Kaplan, J., Mirshahi, F., Setiawan, V. W., Sanyal, A. J., & Rosen, H. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236353 · Cited by 25
A Comparative Proteomic Analysis of Extracellular Vesicles Associated With Lipotoxicity
Nakao, Y., Fukushima, M., Mauer, A. S., Liao, C., Ferris, A., Dasgupta, D., Heppelmann, C. J. H., Vanderboom, P. M., Saraswat, M., Pandey, A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.735001 · Cited by 26
Self-citationAkazawa, Y., & Nakao, K. (2016) · Hepatology Research · doi:10.1111/hepr.12658 · Cited by 25
Eguchi, A., Iwasa, M., & Nakagawa, H. (2022) · Liver International · doi:10.1111/liv.15490 · Cited by 24
Mao, T., Sun, Y., Xu, X., & He, K. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000234 · Cited by 25
Metabolic injury of hepatocytes promotes progression of NAFLD and AALD
Carvalho-Gontijo, R., Han, C., Zhang, L., Zhang, V., Hosseini, M., Mekeel, K., Schnabl, B., Loomba, R., Karin, M., Brenner, D. A., et al. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1755316 · Cited by 23
Decoding the role of extracellular vesicles in liver diseases
Deng, F., Magee, N. S., & Zhang, Y. (2017) · Liver Research · doi:10.1016/j.livres.2017.11.003 · Cited by 24
Lee, J., Choi, W. G., Rhee, M., & Lee, S. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0184 · Cited by 31
Min, R. W. M., Aung, F. W. M., Liu, B., Arya, A., & Win, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082035 · Cited by 22
Ipsen, D. H., & Tveden‐Nyborg, P. (2021) · Biomedicines · doi:10.3390/biomedicines9010093 · Cited by 22
Xu, H. Z., Cheng, M., Chi, X., Liu, X., Zhou, J., Lin, T., & Yang, W. Z. (2019) · Journal of Virology · doi:10.1128/jvi.00758-19 · Cited by 21
The Role of Extracellular Vesicles in Liver Pathogenesis
Liu, G., & Yin, X. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.06.007 · Cited by 21
Extracellular vesicles: catching the light of intercellular communication in fibrotic liver diseases
Li, Y., Wu, J., Liu, R., Zhang, Y., & Li, X. (2022) · Theranostics · doi:10.7150/thno.77256 · Cited by 21
Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation
Gallo, K. A., Ellsworth, E. L., Stoub, H., & Conrad, S. E. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107457 · Cited by 21
Liquid biopsy in chronic liver disease
Barrera-Saldaña, H. A., Fernández-Garza, L. E., & Barrera‐Barrera, S. A. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.03.008 · Cited by 21
The role of hepatocyte-derived extracellular vesicles in liver and extrahepatic diseases
Li, S., Fang, C. R., Zhang, Z., Xu, R., Shi, H., & Yan, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117502 · Cited by 21
Shabangu, C. S., Huang, J., Hsiao, H., Yu, M., Chuang, W., & Wang, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103732 · Cited by 21
Role of Extracellular Vesicles in Liver Diseases
Tamási, V., Németh, K., & Csala, M. (2023) · Life · doi:10.3390/life13051117 · Cited by 20
Magee, N. S., Zou, A., Ghosh, P., Ahamed, F., Delker, D. A., & Zhang, Y. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49910-8 · Cited by 20
Lee, C., Han, J., & Jung, Y. (2022) · Biology · doi:10.3390/biology11050637 · Cited by 19
Role of extracellular vesicles in nonalcoholic fatty liver disease
Jiang, W., Xu, Y., Chen, J.-C., Lee, Y.-H., Hu, Y., Liu, C., Chen, E., Tang, H., Zhang, H., & Wu, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1196831 · Cited by 20
Wu, X., Zhang, Y., Qiu, J., Xu, Y. J., Zhang, J., Huang, J., Bai, J., Huang, Z., Qiu, X., & Xu, W. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.569144 · Cited by 18
Extracellular Vesicles in Liver Diseases: Meeting Report from the International Liver Congress 2018
Bañales, J. M., Feldstein, A. E., Sänger, H., Lukacs‐Kornek, V., Szabó, G., & Kornek, M. (2019) · Hepatology Communications · doi:10.1002/hep4.1300 · Cited by 18
Trifylli, E.-M., Kriebardis, A. G., Koustas, E., Papadopoulos, N., Deutsch, M. J., Aloizos, G., Fortis, S. P., Papageorgiou, E. G., Tsagarakis, A., & Manolakopoulos, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012185 · Cited by 17
Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration
Kelty, T. J., Dashek, R. J., Arnold, W. D., & Rector, R. S. (2023) · Seminars in Liver Disease · doi:10.1055/s-0043-1762585 · Cited by 19
Boeckmans, J., Michel, M. S., Gieswinkel, A., Tüscher, O., Konstantinides, S., König, J., Münzel, T. F., Lackner, K. J., Kerahrodi, J. G., Schuster, A. K.-G., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101171 · Cited by 17
Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_4 · Cited by 18
van Son, K. C., Verschuren, L., Hanemaaijer, R., Reeves, H. L., Takkenberg, R. B., Drenth, J. P. H., Tushuizen, M. E., & Holleboom, A. G. (2023) · Cancers · doi:10.3390/cancers15041308 · Cited by 17
Magee, N. S., Zou, A., Ghosh, P., Ahamed, F., Delker, D. A., & Zhang, Y. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010233 · Cited by 16
García, N. A., Mellergaard, M., González‐King, H., Salomón, C., & Handberg, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713326 · Cited by 15
Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
Qi, X., & Lai, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113501 · Cited by 14
Zivko, C., Fuhrmann, G., & Luciani, P. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129559 · Cited by 13
Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease
Tamimi, A., Javid, M., Sedighi-Pirsaraei, N., & Mirdamadi, A. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1420281 · Cited by 14
Nonalcoholic Steatohepatitis Promoting Kinases
Ibrahim, S. H., Hirsova, P., Malhi, H., & Gores, G. J. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1713115 · Cited by 13
Self-citationKoenen, M. T., Brandt, E. F., Kaczor, D., Caspers, T., Heinzmann, A. C. A., Fischer, P., Heinrichs, D., Wirtz, T. H., Trautwein, C., Koenen, R. R., et al. (2022) · Biomolecules · doi:10.3390/biom12050698 · Cited by 13
Wang, Q., Tang, X., Wang, Y., Zhang, D.-Y., Li, X., & Liu, S. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.009 · Cited by 12
Wang, J., Bao, S., An, Q., Li, C., & Feng, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1544012 · Cited by 14
Yang, D., & Liu, J. (2020) · Liver International · doi:10.1111/liv.14579 · Cited by 12
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis
Chung, K. W., Cho, Y. E., Kim, S.-J., & Hwang, S. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01379-1 · Cited by 11
Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease
Sun, J., Zhang, D., & Li, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.909518 · Cited by 12
Extracellular Vesicles in Hepatobiliary Health and Disease
Parthasarathy, G., Hirsova, P., Kostallari, E., Sidhu, G. S., Ibrahim, S. H., & Malhi, H. (2023) · Comprehensive physiology · doi:10.1002/cphy.c210046 · Cited by 18
Self-citationZeng, J., Liu, X. L., Xin, F., Zhao, Z. H., Shao, Y. L., Yang, R., Pan, Q., & Fan, J. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12845 · Cited by 10
James, K., Bryl‐Górecka, P., Olde, B., Gidlöf, O., Törngren, K., & Erlinge, D. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02756-w · Cited by 10
Multicolor Two-Photon Microscopy Imaging of Lipid Droplets and Liver Capsule Macrophages In Vivo
Kim, E. S., Lee, J.-M., Kwak, J.-Y., Lee, H. W., Lee, I.-J., & Kim, H. M. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00228 · Cited by 10
Warasnhe, K., Sano, A., Guo, Q., Satthawiwat, N., Dai, X., Classon, P., Meroueh, C., Lee, H. S. K., Valenzuela-Pérez, L., Victorelli, S. G., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101633 · Cited by 10
Self-citationLei, Y., Liu, M., & Tao, X. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010116 · Cited by 10
Malhi, H., & Gores, G. J. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch7 · Cited by 9
Self-citationRho-associated protein kinase 1 inhibition in hepatocytes attenuates nonalcoholic steatohepatitis
Dohnálková, E., Bayer, R. L., Guo, Q., Bamidele, A. O., Lee, H. S. K., Valenzuela-Pérez, L., Krishnan, A., Pavelko, K. D., Guisot, N. E. S., Bunyard, P., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000171 · Cited by 8
Self-citationAn Exploration of Non-Coding RNAs in Extracellular Vesicles Delivered by Swine Anterior Pituitary
Xiong, J., Zhang, H., Zeng, B., Liu, J., Luo, J., Chen, T., Sun, J., Xi, Q., & Zhang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.772753 · Cited by 8
The promise of small particles: extracellular vesicles as biomarkers in liver pathology
Srinivas, A. N., Suresh, D., Kaur, S., & Kumar, D. P. (2022) · The Journal of Physiology · doi:10.1113/jp283074 · Cited by 8
Li, J., Zhang, M., Wang, P., Wang, L., Peng, L., Du, R., Han, L., Zhang, P., Wang, Y., & Jiang, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.983428 · Cited by 9
Zhang, X., Li, X., & Xiong, X. (2023) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2023.102230 · Cited by 7
Boonkaew, B., Satthawiwat, N., Pachane, B. C., Brett, L. M., Tangkijvanich, P., & Ariyachet, C. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2025.04.007 · Cited by 8
Boonkaew, B., Charoenthanakitkul, D., Suntornnont, N., Ariyachet, C., & Tangkijvanich, P. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i9.108259 · Cited by 10
Wu, X., Xie, L., He, J., Yan, X., Zhang, F.-F., Xu, Y., & Li, Y. (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123898 · Cited by 6
Molecular insights into the role of mixed lineage kinase 3 in cancer hallmarks
Ke, R., Kumar, S., Singh, S. K., Rana, A., & Rana, B. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189157 · Cited by 6
McCullough, R. L., Saikia, P., Pollard, K. A., McMullen, M. R., Nagy, L. E., & Roychowdhury, S. (2016) · Gene Expression · doi:10.3727/105221616x691730 · Cited by 6
Broad Spectrum Mixed Lineage Kinase Type 3 Inhibition and HIV-1 Persistence in Macrophages
Saminathan, P., Kevadiya, B. D., Marker, D. F., Gendelman, H. E., Gorantla, S., & Gelbard, H. A. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-09829-8 · Cited by 6
Mellergaard, M., Askeland, A., Rasmussen, R. W., Cliff, K. L., Nielsen, M. H., Eschen, R. B., Christiansen, G., Vestergaard, P., Frøkjær, J. B., & Handberg, A. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70257 · Cited by 5
Mullin, S. M., Kelly, A. J., Chathail, M. B. N., Norris, S., Shannon, C. E., & Roche, H. M. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100375 · Cited by 10
MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathway
Ke, R., Viswakarma, N., Menhart, M., Singh, S. K., Kumar, S., Srivastava, P., Vishnoi, K., Kashyap, T., Srivastava, D., Nair, R. S., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03055-8 · Cited by 5
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis
Rosso, C., Demelas, C., Agostini, G., Abate, M. L., Vernero, M., Caviglia, G. P., D’Amato, D., Armandi, A., Tapparo, M., Guariglia, M., et al. (2022) · Viruses · doi:10.3390/v14112397 · Cited by 4
EXOSOMES FROM CYCLIC MICE MODULATE LIVER TRANSCRIPTOME IN ESTROUPAUSE MICE INDEPENDENT OF AGE
Zanini, B. M., Ávila, B. M., Hense, J. D., Garcia, D. N., Ashiqueali, S., Alves, P. I. C., Oliveira, T. L., Collares, T. V., Brieño‐Enríquez, M. A., Mason, J. B., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112508 · Cited by 3
Dong, H., Guo, W., & Zhou, Z. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48010092 · Cited by 4
Mitochondrial dysfunction in MASH: Focusing on chronic inflammation and intercellular communication
Luo, W., Yu, M., Zheng, C., Li, X., Ma, X., Zeng, G., Zhang, J., Ji, X., & Sun, L. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153356 · Cited by 3
Montoya‐Buelna, M., Ramírez-López, I. G., Juan-García, C. A. S., Garcia-Regalado, J. J., Millan-Sanchez, M. S., la Cruz-Mosso, U. D., Haramati, J., Pereira-Suárez, A. L., & Macías‐Barragán, J. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i9.1211 · Cited by 3
Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis
Tu, T., Alba, M. M., Datta, A. A., Hong, H., Hua, B., Jia, Y., Khan, J., Nguyen, P., Niu, X., Pammidimukkala, P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.958696 · Cited by 3
Extracellular Vesicles and Fatty Liver
Lu, X., Song, M., & Gao, N. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_9 · Cited by 3
Metadata
- Authors
- Ibrahim, S. H., Hirsova, P., Tomita, K., Bronk, S. F., Werneburg, N. W., Harrison, S. A., Goodfellow, V. S., Malhi, H., & Gores, G. J.
- Affiliations
- Mayo Clinic (US)
- Brooke Army Medical Center, Fort Sam Houston,Houston,TX
- Califia Bio (United States) (US)
- Corresponding author
- Gores, Gregory J.
- Venue
- Hepatology
- Published
- 2015-12-11
- Volume
- 63
- Issue
- 3
- Pages
- 731-744
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC4764421
- OpenAlex
- W2146229869
- Cited by
- 232
- References
- 41
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 22 · 2023: 24 · 2022: 34 · 2021: 29 · 2020: 37 · 2019: 23 · 2018: 19 · 2017: 14 · 2016: 10 · 2015: 1
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- National Institutes of Health (KL2TR000136, DK97178)
- Center for Cell Signaling in Gastroenterology, Mayo Clinic (P30 DK084567)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK097178, DK-41876, R37DK041876, R01DK041876, P30DK084567, DK 97178)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- MLK3, CXCL10, extracellular vesicles, lipotoxicity, hepatocytes, macrophage chemotaxis, nonalcoholic steatohepatitis, lysophosphatidylcholine, palmitate, chemokine secretion, CD63
- MeSH terms
- Extracellular Vesicles, Mitogen-Activated Protein Kinase Kinase Kinase 11, Animals, Chemotaxis, Disease Models, Animal, Humans, Liver, Macrophages, Signal Transduction, MAP Kinase Kinase Kinases, Hepatocytes, Cell Line, Tumor, Mice, Chemokine CXCL10, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review